Target intelligence / Profile preview

CS17 fimbriae minor tip adhesin CsbD (CsbD) (CsbD)

Target
CsbD
Molecular classification
Adhesin, Bacterial surface protein, Pilin
01

Overview

CsbD is the minor tip adhesin protein of the CS17 fimbriae, which are expressed by Enterotoxigenic Escherichia coli (ETEC). ETEC is a leading cause of bacterial diarrhea in children in developing countries and a major cause of traveler's diarrhea worldwide (UniProt P0CL58). The CS17 fimbriae belong to the CFA/I-like family of pili and are essential for the bacteria's ability to adhere to and colonize the human small intestine (PubMed: 9264057). CsbD is located at the distal tip of the fimbrial shaft and is responsible for the specific recognition and binding of host cell receptors, a critical step in the pathogenesis of ETEC (PubMed: 28808153). Because it is vital for the initial stages of infection, CsbD is a significant target for the development of vaccines and anti-adhesion therapies. Targeting CsbD aims to prevent the establishment of infection by neutralizing the bacteria's ability to attach to the gut wall, thereby preventing toxin delivery and subsequent disease (PubMed: 31406100). Current research focuses on including CsbD or related fimbrial antigens in multivalent oral vaccines to provide broad protection against various ETEC strains. Anti-adhesive drugs that mimic host receptors are also being explored to competitively inhibit CsbD-mediated binding.

Other names
CsbD proteinCS17 minor pilinCS17 adhesin subunit
02

Mechanism of action

Inhibition of bacterial attachment to host intestinal epithelium by blocking the interaction between the fimbrial tip and host receptors.

03

Biological functions

Bacterial adhesionHost cell attachmentIntestinal colonization
04

Disease associations

InfectionDiarrheaEnterotoxigenic Escherichia coli infection
05

Safety considerations

Strain-specific efficacyPotential for immune evasion through antigenic variationVaccine-induced gastrointestinal side effects
06

Interacting drugs

Investigational ETEC vaccines (e.g., ETVAX components)

1 more in the full profile.

07

Biomarkers

CS17 fimbriae expressionETEC-specific DNA sequences (csbD gene)Anti-CS17 antibody titers

Beyond the preview

Go deeper on CS17 fimbriae minor tip adhesin CsbD (CsbD) (CsbD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CS17 fimbriae minor tip adhesin CsbD (CsbD) (CsbD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call